Juan Latorre, MD
Physical Medicine & Rehabilitation · Austin, TXNPI 1841269263
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Ossur Americas, Inc. accounts for 74.3% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $610, more than ten times the $16 reported in 2021.
Across 44 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ossur Americas, Inc.$593
- AbbVie$137
- Dentsply IH AB$19
- Gilead$17
- Viiv Healthcare Company$16
- Medtronic$15
What the payments were for
- Food & beverage$797100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ossur Americas, Inc. | 38 | $593 |
| AbbVie | 2 | $137 |
| Dentsply IH AB | 1 | $19 |
| Gilead | 1 | $17 |
| Viiv Healthcare Company | 1 | $16 |
| Medtronic | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$120
How this compares
$797 in reported general payments places this provider in the 75th percentile of 651 physical medicine & rehabilitation providers in Texas.
See all physical medicine & rehabilitation providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 76 | $2,056 |
| Gabapentin | 97 | $1,054 |
| Methocarbamol | 43 | $456 |
| Duloxetine Hcl | 18 | $250 |
| Oxycodone Hcl | 34 | $223 |
| Pregabalin | 24 | $221 |
| Tizanidine Hcl | 23 | $181 |
| Tramadol Hcl | 32 | $180 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $172 |
| Tamsulosin Hcl | 17 | $93 |
| Pantoprazole Sodium | 11 | $49 |
| Trazodone Hcl | 13 | $42 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Austin
- Jose UrquidezAustin$332K
- Joseph OwensAustin$9K
- Vishal KancherlaAustin$5K
- Anand JoshiAustin$4K
- Lisa PersynAustin$3K
- Gerard FranciscoHouston$364K
- Gireesh ShardaDallas$172K
- Suzanne ManziHouston$143K
- Cindy IvanhoeHouston$111K
- Chad McNeilTyler$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.